Dr. Reddys Laboratories Ltd.

The Exchange has sought clarification from Dr Reddys Laboratories on March 21, 2017, with reference to news flashed on ET Now dated March 21, 2017 quoting ‘US FDA finds repeat observations from 2015 warning letter. Failed to maintain complete data to ensure compliance.’

The above information is a part of company’s filings submitted to BSE.